Related Experiment Video
Updated: Aug 11, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Antithrombotic agents are indicated in the therapy of acute myocardial infarction
Insights
Despite lacking statistical proof, anticoagulant therapy is recommended for acute myocardial infarction patients to prevent thromboembolism, unless contraindicated. Treatment is continued for questionable cases until diagnosis is confirmed or rejected.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute myocardial infarction poses a significant risk of thromboembolic complications.
- The efficacy of coumarin drugs in treating acute myocardial infarction lacks statistical validation.
- Clinical and pathological observations suggest potential benefits of anticoagulants.
Purpose of the Study:
- To provide guidance on the use of anticoagulant therapy in patients with acute myocardial infarction.
- To address the therapeutic dilemma between potential benefits and lack of definitive proof for anticoagulants.
Main Methods:
- Review of clinical and pathological impressions regarding anticoagulant use.
- Development of a treatment strategy based on diagnostic certainty and contraindications.
Main Results:
- Recommended anticoagulant treatment for all patients with confirmed acute myocardial infarction during hospitalization, barring contraindications or laboratory deficiencies.
- Suggested anticoagulant use for patients with questionable infarcts until diagnosis is established or ruled out.
- Advised withholding anticoagulants if pain is suspected to originate from pericarditis, dissecting aneurysm, or gastrointestinal issues.
Conclusions:
- Anticoagulant therapy is a pragmatic choice for acute myocardial infarction patients due to high thromboembolism risk, despite unproven efficacy.
- Treatment protocols should be individualized based on diagnostic certainty and patient-specific factors.
- Careful consideration of differential diagnoses is crucial before initiating anticoagulant therapy.
Abstract:
Although there is no statistical proof of the efficacy of coumarin drugs in the therapy of acute myocardial infarction, the numbers of patients at risk from thromboembolism are sufficiently great and the favorable clinical and pathologic impressions are sufficiently strong that, conversely, the possibility of benefit cannot be excluded. This delicate balance is indeed a Hobson's Choice. In this therapeutic dilemma, we would interpret one acceptable course in regard to the use of anticoagulants among patients with acute myocardial infarction as follows: all patients with proved acute myocardial infarction should be treated with anticoagulants while hospitalized unless there are relative or absolute contraindications to the therapy or deficiencies in laboratory facilities. Patients with questionable infarcts should be treated with anticoagulants only until the diagnosis is established or rejected. If the latter occurs, the administration of the drug should be discontinued. When, in a patient suspected of having an acute myocardial infarction, there is reason to believe that the pain may be due to pericarditis, dissecting aneurysm, or gastrointestinal abnormalities, anticoagulant therapy should be withheld until this is resolved.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:14Myocarditis III: Medical Management
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:29Venous Thrombosis III: Interprofessional Care